Vanda Pharmaceuticals Calls for Stronger FDA Action to Accelerate Shift from Animal Testing to Human-Relevant Methods
Go back to Vanda Pharmaceuticals Calls for Stronger FDA Action to Accelerate Shift from Animal Testing to Human-Relevant Methods| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 6.23 -0.15 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.38 | 52 Week High | $18.00 | |||
| Open | $6.35 | 52 Week Low | $6.91 | |||
| Day High | $6.36 | P/E | N/A | |||
| Day Low | $6.15 | EPS | $-0.67 | |||
| Volume | 71,872 | |||||
